The company reported doubling revenues in 2011 and plans to use the new funds to support ongoing sales and marketing expansion, research and development for new product lines and building out of manufacturing infrastructure.
“This latest round of funding provides us with the resources to aggressively grow our business and invest in our scale up,” said CEO and chairman of the board Philipp Lang, MD, MBA. “It also provides us with the resources to pursue strategic initiatives in technology and intellectual property expansion.”
Related Articles on Orthopedic Devices:
NuVasive Shares Rise After Judge’s Ruling
Zimmer’s 2.9% Sales Increase Driven by Foreign Markets
Interventional Spine Receives FDA Clearance for Spine Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
